Skip to main content
Industry News
Startup cancer researcher Repertoire raises $189M
4/15/2021

Repertoire, a startup working on anti-cancer T-cell therapies, raised $189 million in its Series B funding round. With the new capital it will continue work on the therapies in its pipeline and enhance the capabilities of its immune response drug discovery platform.

Full Story: